ArticleCell2023
KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres.
Nazario Bosco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this papercites it
ArticleCell2023
Nazario Bosco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.